Loading...

Brilliant Violet 605™ anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1.4_BV605_Ly-6C_Antibody_FC_072313
C57BL/6 mouse bone marrow cells were stained with Ly-6C (clone HK1.4) Brilliant Violet 605™ (filled histogram). Open histogram represents non-stained cells. Data shown was gated on the myeloid population.
  • HK1.4_BV605_Ly-6C_Antibody_FC_072313
    C57BL/6 mouse bone marrow cells were stained with Ly-6C (clone HK1.4) Brilliant Violet 605™ (filled histogram). Open histogram represents non-stained cells. Data shown was gated on the myeloid population.
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Quantity Check Availability Save
128035 125 µL 168€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128036 500 µL 344€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  2. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  3. Alkhani A, et al. 2020. Sci Rep. 10:7165. PubMed
  4. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  5. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  6. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  7. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  8. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  9. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  10. Zarban AA, et al. 2023. JID Innov. 3:100154. PubMed
  11. Lin YH 2023. Immunity. 56(1):207-223.e8. PubMed
  12. Glaubitz J, et al. 2023. Gut. :. PubMed
  13. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  14. Chang CY, et al. 2022. Sci Adv. 8:eabq0615. PubMed
  15. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  16. Corria-Osorio J, et al. 2023. Nat Immunol. 24:869. PubMed
  17. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  18. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  19. Gawish R, et al. 2022. Elife. 11:. PubMed
  20. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  21. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  22. Han SJ et al. 2017. Immunity. 47(6):1154-1168 . PubMed
  23. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  24. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  25. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  26. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  27. Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
  28. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  29. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  30. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  31. Kedage V, et al. 2022. MAbs. 14:2040083. PubMed
  32. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  33. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  34. Zhou Y, et al. 2020. Immunity. 52(2):357-373. PubMed
  35. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  36. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
  37. Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed
  38. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  39. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  40. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  41. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  42. Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
  43. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  44. Tondini E, et al. 2022. NPJ Vaccines. 7:64. PubMed
  45. Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed
  46. Hassan AO, et al. 2021. Cell Reports. 36(4):109452. PubMed
  47. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  48. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  49. Da Silva CG, et al. 2019. Theranostics. 4.878472222. PubMed
  50. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  51. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  52. Beura LK, et al. 2018. Immunity. 48:327. PubMed
  53. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  54. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  55. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  56. Giampazolias E, et al. 2021. Cell. . PubMed
  57. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  58. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  59. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  60. Winkler ES, et al. 2020. Nat Immunol. 21:1327. PubMed
  61. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  62. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  63. Soncin I, et al. 2018. Nat Commun. 9:582. PubMed
  64. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  65. Lam KC, et al. 2021. Cell. 184:5338. PubMed
  66. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  67. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  68. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  69. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  70. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  71. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  72. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  73. Sheng J, et al. 2021. eLife. 10:00. PubMed
  74. Mathur AN, et al. 2019. Immunity. 50:655. PubMed
  75. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  76. Perez-Cruz M, et al. 2021. PLoS One. e0236216:16. PubMed
  77. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  78. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  79. Young K, et al. 2021. Cell Stem Cell. . PubMed
  80. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  81. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  82. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  83. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID
AB_2562352 (BioLegend Cat. No. 128035)
AB_2562352 (BioLegend Cat. No. 128036)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account